Detalhe da pesquisa
1.
Overactive bladder - 18 years - Part I.
Int Braz J Urol
; 42(2): 188-98, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27176184
2.
Overactive bladder - 18 years - Part II.
Int Braz J Urol
; 42(2): 199-214, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27176185
3.
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.
Eur Urol Oncol
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38582650
4.
Atypical presentation of COVID-19: Chronic bilateral testicular pain with lower extremity peripheral polyneuropathy, case report.
Urol Case Rep
; 40: 101932, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34778003
5.
Increasing Immune Dysfunction is Associated with Increasing Matrix-Metalloproteinase-2 Expression and Predicts Biochemical Failure in Men with Bone Marrow Micro-Metastasis Positive Localized Prostate Cancer.
Asian Pac J Cancer Prev
; 23(7): 2497-2505, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35901359
6.
The CAPRA-S Score and Immune Dysfunction as a Guide to Outcome in Men Treated with Prostatectomy Radical as Mono-Therapy for Prostate Cancer.
Arch Esp Urol
; 75(6): 507-516, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138499
7.
[CAPRA score vs minimal residual disease as predictors of biochemical recurrence after radical prostatectomy.] / La puntuación CAPRA frente a los subtipos de enfermedad residual mínima para predecir la recidiva bioquímica después de la prostatectomía radical.
Arch Esp Urol
; 74(6): 554-563, 2021 Jul.
Artigo
em Espanhol
| MEDLINE | ID: mdl-34219057
8.
Platelet-to-lymphocyte ratio and systemic immune-inflammation index versus circulating prostate cells to predict significant prostate cancer at first biopsy.
Turk J Urol
; 46(2): 115-122, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32053099
9.
The Epstein criteria predict for organ-confined prostate cancer but not for minimal residual disease and outcome after radical prostatectomy.
Turk J Urol
; 46(5): 360-366, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32707032
10.
The expression of matrix-metalloproteinase-2 in bone marrow micro-metastasis is associated with the presence of circulating prostate cells and a worse prognosis in men treated with radical prostatectomy for prostate cancer.
Turk J Urol
; 46(3): 186-195, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32401703
11.
The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy.
Ecancermedicalscience
; 14: 1063, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728379
12.
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy.
Ecancermedicalscience
; 14: 1042, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565895
13.
Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study.
Urol J
; 17(3): 262-270, 2020 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912475
14.
[Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer.] / Células prostáticas circulantes y micro-metástasis en médula ósea determinantes en el riesgo y en el tiempo de progresión bioquímica en cáncer prostático localizado.
Arch Esp Urol
; 72(5): 471-482, 2019 Jun.
Artigo
em Espanhol
| MEDLINE | ID: mdl-31223125
15.
[Circulating prostate cells and bone marrow micro-metastasis and not treatment modality determine the risk and time to biochemical failure in low risk prostate cancer.] / La enfermedad mínima residual y no el tratamiento predice la recidiva bioquímica en sujetos con cáncer prostático de bajo riesgo.
Arch Esp Urol
; 72(10): 1000-1009, 2019 Dec.
Artigo
em Espanhol
| MEDLINE | ID: mdl-31823848
16.
Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy.
Ecancermedicalscience
; 13: 934, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31281431
17.
Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells.
Asian Pac J Cancer Prev
; 20(11): 3385-3389, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31759363
18.
Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
Asian Pac J Cancer Prev
; 19(1): 229-236, 2018 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29374406
19.
The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy.
Ecancermedicalscience
; 12: 844, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30034521
20.
Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the Literature.
Case Rep Hematol
; 2018: 9750532, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30534450